Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

ClinicalTrials.gov ID: NCT00002359

Public ClinicalTrials.gov record NCT00002359. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 16, 2026, 5:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Regardless of Concomitant HIV Therapies

Study identification

NCT ID
NCT00002359
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
The Immune Response Corporation
Industry
Enrollment
3,000 participants

Conditions and interventions

Conditions

Interventions

  • HIV-1 Immunogen Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
54
U.S. states
27
U.S. cities
43
Facility City State ZIP Site status
Phoenix Body Positive Phoenix Arizona 85016
Ctr for Special Immunology Irvine California 92718
Jeffrey Goodman Special Care Clinic Los Angeles California 90028
Kraus Med Partners Los Angeles California 90036
Cedars Sinai Med Ctr Los Angeles California 90048
AIDS Community Research Consortium Redwood City California 94063
Whitman Walker Clinic Inc Washington D.C. District of Columbia 20009
Anderson Clinical Research Washington D.C. District of Columbia 20037
George Washington Univ Med Ctr Washington D.C. District of Columbia 20037
North Broward Hosp District Fort Lauderdale Florida 33316
Ctr for Special Immunology Miami Beach Florida 33140
The Coleman Institute North Miami Florida 33179
Clinical Pharmacology Services Tampa Florida 33617
AIDS Research Consortium of Atlanta Atlanta Georgia 30308
Rush Med Ctr Chicago Illinois 60612
Chicago AIDS Research Alliance Chicago Illinois 60657
Ctr for Special Immunology Chicago Illinois 60657
Community Hosp Indianapolis Indianapolis Indiana 46219
UKSM-W Med Practice Association Wichita Kansas 67214
Univ of Kentucky / Division of ID Research Lexington Kentucky 40536
JSI Research and Training Institute Boston Massachusetts 02210
Community Research Initiative of New England Brookline Village Massachusetts 02445
Providence Mercy Hosp Holyoke Massachusetts 01040
Wayne State Univ / WSU / DMC HIV / AIDS Program Detroit Michigan 48201
Henry Ford Hosp / Infectious Diseases Detroit Michigan 48202
Abbott Northwestern Hosp Minneapolis Minnesota 55407
Kansas City AIDS Research Consortium Kansas City Missouri 64111
Washington Univ / St Louis Connect Care St Louis Missouri 63108
Anderson Clinical Research New York New York 10016
St Luke's - Roosevelt Hosp Ctr / Div of Infect Dis New York New York 10019
Cornell Univ Med College New York New York 10021
Mount Sinai Med Ctr New York New York 10029
Dr Barbara Justice New York New York 10031
Community Health Network Rochester New York 14620
Bronx Lebanon Hosp Ctr The Bronx New York 10456
Nalle Clinic Charlotte North Carolina 28207
Univ of Cincinnati Med Ctr / Holmes Division Cincinnati Ohio 45267
Ohio State Univ / Division of Infectious Disease Columbus Ohio 43210
Univ of Oklahoma Oklahoma City Oklahoma 73117
The Research and Education Group Portland Oregon 97210
The Graduate Hosp Philadelphia Pennsylvania 19146
Anderson Clinical Research Pittsburgh Pennsylvania 15218
Mem Hosp of Rhode Island Pawtucket Rhode Island 02860
Med Univ of South Carolina Charleston South Carolina 29425
Vanderbilt Univ Med Ctr Nashville Tennessee 37212
Metroplex Clinical Research Ctr Dallas Texas 75235
Univ of Texas Med Branch Ctr for Clinical Studies Galveston Texas 77555
ONCOL Med Associates / PA Houston Texas 77027
Univ of Utah Med School / Clinical Trials Ctr Salt Lake City Utah 84108
Infectious Disease Physicians Inc Annandale Virginia 22003
Hampton Roads Med Specialists Hampton Virginia 23666
Eastern Virginia Med School Norfolk Virginia 23507
Novum Inc Seattle Washington 98104
Wisconsin AIDS Research Consortium Milwaukee Wisconsin 53203

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002359, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced May 16, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002359 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →